These findings suggest that an increased share of ATF4 is “occupied” by CREB3L2 in AD brains, indicating that an overall shift in ATF4 and CREB3L2 dimerization patterns occurs in association with this neurodegenerative condition. The gene discussed is ATF4; the disease is Alzheimer disease.